← Eichor
Condition: Pharmacokinetic Study In Healthy Volunteers Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pharmacokinetic Study In Healthy Volunteers

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Clinical Study of AK0610
Phase 1 · 1 location(s) · Shanghai Ark Biopharmaceutical Co., Ltd. · NCT06996704Safety, Tolerability, PK and PD of SSS55 in Healthy Subjects
Phase 1 · 1 location(s) · Shenyang Sunshine Pharmaceutical Co., LTD. · NCT07058779A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants
Phase 1 · 3 location(s) · Beijing QL Biopharmaceutical Co.,Ltd · NCT07443059A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects
Phase 1/Phase 2 · 4 location(s) · Clearmind Medicine Inc. · NCT05913752Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects
Phase 1 · 1 location(s) · Beijing Tide Pharmaceutical Co., Ltd · NCT07301203Pharmacokinetic Study of Sudapyridine（WX-081）in Healthy Chinese Subjects
Phase 1 · 1 location(s) · Shanghai Jiatan Pharmatech Co., Ltd · NCT06701110Nalmefene Implant in Healthy Subjects
Phase 1 · 1 location(s) · ReacX Pharmaceuticals, Inc. · NCT07325279Pharmacokinetic Study of Oligonucleotides in Maixuekang Capsules
Phase 1 · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06823895A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes
Phase 1 · 1 location(s) · Novo Nordisk A/S · NCT07270731A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
Phase 1 · 1 location(s) · Usynova Pharmaceuticals Ltd. · NCT07038720A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
Phase 1 · 1 location(s) · Novo Nordisk A/S · NCT07437079A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tabl
Phase 1 · 1 location(s) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · NCT07694869A Phase I Clinical Study of a Single Dose of KLA480
Phase 1 · 1 location(s) · Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. · NCT07030790A Bioequivalence Study Between Two Casdatifan Tablet Strengths and Food Effect Study of Casdatifan in Healthy Adult Part
Phase 1 · 1 location(s) · Arcus Biosciences, Inc. · NCT07641881Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers
Phase 1 · 1 location(s) · Il-Yang Pharm. Co., Ltd. · NCT07433556Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers
Phase 1 · 1 location(s) · Bichedam Co., Ltd. · NCT07282145to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin
Phase 1 · 1 location(s) · Onconic Therapeutics Inc. · NCT07265466Safety, Tolerability, and Pharmacokinetic Profile of Grammidin With Anesthetic, a Metered Dose Topical Spray in Healthy
Phase 1 · 1 location(s) · Valenta Pharm JSC · NCT06857890A Study to Assess the Absolute Bioavailability of Empasiprubart SC Administered With an Autoinjector and the Pharmacokin
Phase 1 · 1 location(s) · argenx · NCT07612020To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers
Phase 1 · 1 location(s) · JW Pharmaceutical · NCT06703710A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy
Phase 1 · 1 location(s) · Shanghai WD Pharmaceutical Co., Ltd. · NCT07442591A Comparison of Fisetin Kinetics in Young and Old Adults
NA · 1 location(s) · University Medicine Greifswald · NCT06796374A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy Volunteers
Phase 1 · 1 location(s) · Hunan Kelun Pharmaceutical Co., Ltd. · NCT07474545Evaluation of the Pharmacokinetics of "PBK_M2301" in Healthy Adults
Phase 1 · 1 location(s) · Pharmbio Korea Co., Ltd. · NCT07161180A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)
Phase 1 · 1 location(s) · Merck Sharp & Dohme LLC · NCT07619443A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and
Phase 1 · 1 location(s) · Korea United Pharm. Inc. · NCT07162441A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorciti
Phase 1 · 1 location(s) · Incyte Corporation · NCT07588139A Pharmacokinetic Study of YN001 in Healthy Participants
Phase 1 · 1 location(s) · Beijing Inno Medicine Co., Ltd. · NCT07190885A Phase 1 Study of the Safety and How the Body Processes ABBV-722 and Upadacitinib After Multiple Oral Doses in Healthy
Phase 1 · 1 location(s) · AbbVie · NCT07425899Safety, Tolerability, and Pharmacokinetics of HL-003 in Healthy Subjects
Phase 1 · 1 location(s) · Shanghai Kechow Pharma, Inc. · NCT06867393
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.